1Aoki FY, Rubin ME, Friesen AD, et al. Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects[J].Journal of biological standardization 1989, 17: 91-104.
2Lang J, Gravenstein S, Briggs D , et al. Evaluation of the safety and immunogenicity of a new, Heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies[J]. Biologicals 1998,26: 7-15.
3Nicholson KG, Turner GS. Studies with human diploid cell strain rabies vaccine and human antirabies immunoglobulin in man[J]. Dev Biol Stand 1978, 40: 115-120.
4WHO Expert Committee on Rabies. Technical report series 709[R]. Geneva 1984,32-33.
5Wilde H, Glueck R, Khawplod P, et al. Efficacy study of a new albumin-free human diploid cell rabies vaccine in 100 severely rabies-exposed Thai patients[J]. Vaccine 1995, 13: 593-596.
6Khawplod P, Glueck R, Wilde H, et al. Immunogenicity of purified duck embryo rabies vaccine with use of the WHO-approved intradermal postexposure regimen[J].Clin Infect Dis 1995, 20:645-651.
7Fangtao L, Shubeng C, Yinzhon W, et al. Use of serum and vaccine in combination for prophylaxis following exposure to rabies[J]. Rev Inf Dis 1988,10(Supp1. 14): 766-770.
8Blancou J, Baltazar RS, Molli I , et al. Effective postexposure treatment of rabies-infected sheep with rabies immune globulin and vaccine[J].Vaccine1991, 9:432-437.
9Loofbourow J, Cabasso V, Roby R , et al. Human rabies immune globulin.Clinical trials and dose determination[J]. JAMA 1971, 217: 1825-1831.
